Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phleum pratense pollen allergy vaccine - HAL Allergy

Drug Profile

Phleum pratense pollen allergy vaccine - HAL Allergy

Alternative Names: Sublivac Fix Grasses; SUBLIVAC FIX Phleum pratense; Sublivac Fix Phleum pratense

Latest Information Update: 24 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator HAL Allergy
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Allergic rhinitis; Allergic rhinoconjunctivitis

Most Recent Events

  • 30 Oct 2018 No development reported - Phase-II for Allergic rhinitis in Canada, Poland, Germany (Sublingual)
  • 30 Oct 2018 No development reported - Phase-II for Allergic rhinoconjunctivitis in Canada, Poland, Germany (Sublingual)
  • 01 Oct 2016 HAL Allergy completes a phase II trial in Allergic rhinitis in Canada (Sublingual) (NCT02556801)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top